Fr. 210.00

Management of Urologic Cancer - Focal Therapy and Tissue Preservation

Inglese · Copertina rigida

Spedizione di solito entro 1 a 3 settimane (non disponibile a breve termine)

Descrizione

Ulteriori informazioni

Immer mehr Urologen und Onkologen entscheiden sich beim Management urologischer Krebserkrankungen für den Erhalt und nicht die Entfernung des betroffenen Gewebes. Dieses Fachbuch erläutert alle verfügbaren Optionen und zeigt das bestmögliche Patientenmanagement. Herausgeber Mark Schoenberg ist ein international anerkannter Experte auf diesem neuen, aufregenden Gebiet und hat ein herausragendes Team zusammengestellt, zu dem einige der führenden Urologen und Onkologen aus Nordamerika und Europa gehören.

Sommario

List of Contributors xiii
 
Preface xvii
 
Cancer Genetics, Cancer Biology, and Tumor Growth and Metastasis: The Interaction of Cancer and Its Host Environment 1
Mark C. Markowski and Kenneth J. Pienta
 
Renal Cell Carcinoma 1
 
Bladder Cancer 3
 
Prostate Cancer 6
 
References 12
 
Pathological Basis of Tumor Characterization: Cytopathology, Surgical Pathology, and How Histo?]Morphology Informs Treatment Decision Making 19
Oleksandr N. Kryvenko and Fadi Brimo
 
The Kidney 23
 
The Urothelium 27
 
The Testis 29
 
References 30
 
The Immunobiology of Tumor Ablation 33
Rafi Kabarriti and Chandan Guha
 
Manipulating the Immune System to Fight Cancer 33
 
Can We Take Advantage of Ablative Therapies to Activate the Immune System? 34
 
Immunomodulatory Properties of HIFU 35
 
Immunomodulatory Properties of Cryotherapy 36
 
Immunomodulatory Properties of Radiation Therapy 37
 
References 38
 
Computed Tomography of Urologic Malignancies: The Role of MDCT in Renal Cell Carcinoma and Transitional Cell Carcinoma 41
Siva P. Raman and Elliot K. Fishman
 
Introduction 41
 
MDCT Protocol Design 41
 
Three?]Dimensional Reconstructions 44
 
Neoplasms of the Intrarenal Collecting Systems, Ureters, and Bladder 45
 
Solid Renal Parenchymal Lesions 49
 
Conclusion 55
 
References 55
 
MRI and Metabolic Imaging 59
Louise Dickinson, Francesco Fraioli, Athar Haroon, and Clare Allen
 
Magnetic Resonance Imaging 59
 
MRI Sequences 59
 
Clinical Applications of MRI for Prostate Cancer 61
 
Clinical Applications of MRI for Renal Cancer 63
 
Clinical Applications of MRI for Bladder Cancer 64
 
New Advances in MRI 65
 
Metabolic Imaging 66
 
Clinical Applications of PET-CT for Prostate Cancer 69
 
Active Surveillance for Low?]Risk Prostate Cancer 113
Laurence Klotz
 
Introduction and Background 113
 
Rationale 113
 
Genetic Features of Low?]Grade Prostate Cancer 114
 
Metastatic Potential 115
 
Limitations of PSA Kinetics 116
 
Role of MRI 116
 
Implications for Patient Management 117
 
Eligibility for Surveillance 118
 
Outcome of Surveillance 119
 
Modeling 119
 
AS in Practice 121
 
Conclusions 121
 
References 122
 
Tissue?]Preserving Surgical Approaches in Urologic Oncology: The Therapeutic Mechanism for Tumor Ablation 127
Ganesh Kartha and J. Stephen Jones
 
Introduction 127
 
Cryoablation: Extreme Cold for Tumor Necrosis 128
 
Conclusion 130
 
References 130
 
Focal Therapy for Prostate Cancer: An Evidence?]Based Approach to Tissue?]Preserving Strategies 133
Kara L. Watts, Yaalini Shanmugabavan, Victoria Chernyak, and Hashim Uddin Ahmed
 
Introduction 133
 
Key Concepts in FT for PCa 134
 
Tissue?]Preserving FTs 135
 
Cryotherapy 135
 
HIFU 137
 
Salvage Focal/Hemiablation HIFU 140
 
IRE 141
 
Radiation 142
 
Additional Therapies 143
 
Implications for Research 144
 
Conclusions 144
 
References 145
 
The Modern Basis for Nephron?]Sparing Surgery in Patients with Renal Cancer: Biologic Heterogeneity, the Significance of Tumor Biopsy, and the Changing Roles of Partial Nephrectomy and Tumor Ablation 151
Jeffrey J. Tomaszewski, Robert G. Uzzo, and David Y.T. Chen
 
Introduction 151
 
Principal Treatment Options for SRMs and the Basis for Nephron Preservation 152
&nbs

Info autore










MARK P. SCHOENBERG, MD, University Professor & Chair, Department of Urology, The Montefiore Medical Center and The Albert Einstein College of Medicine, Bronx, NY, USA KARA L. WATTS, MD, Assistant Professor, Department of Urology, The Montefiore Medical Center and The Albert Einstein College of Medicine, Bronx, NY, USA

Riassunto

Managing urologic cancer by preserving, as opposed to removing, affected tissue, is rapidly becoming the favoured choice for urologists and oncologists. Discover all available options and how to achieve the best possible patient management with this expert guide to the area.

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.